A number of companies came public this week, including Q&K International (QK), Galera Therapeutics (GRTX), Silvergate Capital (SI), Centogene (CNTG), TELA Bio (TELA), CNS Pharmaceuticals (CNSP), 36Kr Holdings (KRKR), and ECMOHO (MOHO).
LATEST IPOS:
Before the market opened on November 5, Q&K International's 2.7M ADS IPO priced at $17.00, at the low end of its $17.00-$19.00 target range. Later that morning, Q&K International opened at $17.35.
After the market close on November 6, Galera Therapeutics' 5M share IPO priced at $12.00, below its $14.00-$16.00 target range. On Thursday, November 7, Galera Therapeutics opened at $12.50.
After the market close on November 6, Silvergate Capital's 3.33M share IPO priced at $12.00, below its $13.00-$15.00 target range. On Thursday, November 7, Silvergate Capital opened at $12.75.
Before the market opened on November 7, Centogene's 4M share IPO priced at $14.00, at the low end of its $14.00-$16.00 target range.
After the market close on November 7, TELA Bio's 4M share IPO priced at $13.00, below its $14.00-$16.00 target range. On Friday, November 8, TELA Bio opened at $13.75.
Before the market opened on November 8, CNS Pharmaceuticals' 2.125M share IPO priced at $4.00, at the low end of its $4.00-$5.00 target range. Later that morning, CNS Pharmaceuticals opened at $4.11.
Before the market opened on November 8, 36Kr Holdings' 1.38M share IPO priced at $14.50, at the low end of its $14.50-$17.50 target range. Later that morning, 36Kr Holdings opened at $12.58.
Before the market opened on November 8, ECMOHO's 4.375M share IPO priced at $10.00, at the low end of its $10.00-$12.00 target range. Later that morning, ECMOHO opened at $10.10.
PERFORMANCE:
POSTPONED DEALS:
89bio (ETNB) was scheduled to be priced on Tuesday, November 5, but the deal has been delayed due to an administrative issue between the auditor and the SEC, according to the underwriter.
GFL Environmental (GFL) was scheduled to be priced on Wednesday, November 6, but the deal has been delayed.
Monopar Therapeutics (MNPR) was scheduled to be priced on Thursday, November 7, but the deal has again been delayed.
"Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, analyst commentary and upcoming IPOs.
Q&K International
-0.04 (-0.21%)
Galera Therapeutics
+0.07 (+0.59%)
Silvergate Capital
+0.29 (+2.28%)
Centogene
+0.56 (+4.62%)
Tela Bio
+ (+0.00%)
CNS Pharmaceuticals
+ (+0.00%)
36Kr Holdings
+ (+0.00%)
ECMOHO
+ (+0.00%)
89bio
+ (+0.00%)
GFL Environmental
+ (+0.00%)
Monopar Therapeutics
+ (+0.00%)